The Goldman Sachs Group Lowers CME Group (NASDAQ:CME) Price Target to $263.00

CME Group (NASDAQ:CME) had its price target decreased by analysts at The Goldman Sachs Group from $264.00 to $263.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The brokerage presently has a “sell” rating on the financial services provider’s stock. The Goldman Sachs Group’s target price suggests a potential downside of 2.91% from the stock’s previous close.

A number of other equities analysts have also recently commented on CME. Jefferies Financial Group reduced their price target on CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a report on Friday, October 10th. UBS Group decreased their target price on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a report on Thursday, October 23rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, CME Group currently has an average rating of “Hold” and an average target price of $289.18.

CME Group Price Performance

Shares of CME opened at $270.87 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company’s fifty day simple moving average is $271.57 and its 200 day simple moving average is $272.80. CME Group has a 1-year low of $224.62 and a 1-year high of $290.79. The company has a market cap of $97.68 billion, a price-to-earnings ratio of 26.25, a PEG ratio of 4.26 and a beta of 0.28.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter last year, the company posted $2.68 earnings per share. On average, research analysts forecast that CME Group will post 10.49 earnings per share for the current fiscal year.

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,147 shares of company stock valued at $562,079 in the last three months. 0.30% of the stock is owned by insiders.

Institutional Trading of CME Group

A number of institutional investors have recently modified their holdings of CME. Webster Bank N. A. lifted its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the period. Caldwell Trust Co boosted its position in shares of CME Group by 116.3% during the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 50 shares in the last quarter. Highline Wealth Partners LLC boosted its position in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in CME Group in the third quarter valued at approximately $27,000. Finally, Financial Consulate Inc. acquired a new position in CME Group during the third quarter valued at approximately $28,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.